Rockland Immunochemicals
Open-data reference.
LIMERICK, PA | Blood derivatives manufacturing
~99 avg employees | 2 years of OSHA data
Rockland Immunochemicals has an average TCR of 0.0, which is 0% of the industry average (3.3) for Blood derivatives manufacturing. This is better than average.
Safety Insights for Rockland Immunochemicals
Rockland Immunochemicals operates an establishment with approximately 99 full-time equivalent workers in LIMERICK, PA, classified under the Blood derivatives manufacturing industry (NAICS 325414). Across 2 years of mandatory OSHA Injury Tracking Application (ITA) reporting, this employer has accumulated 0 recordable injuries, 0 occupational illnesses, and 0 workplace fatalities. The average Total Case Rate (TCR) of 0.0 injuries per 100 full-time workers per year provides the anchor metric for the C letter grade (Average Safety Record).
Benchmarked against the Bureau of Labor Statistics industry average of 3.3 for Blood derivatives manufacturing, Rockland Immunochemicals's workforce experiences 0% of the typical injury burden. This ratio matters because TCR already normalizes for hours worked — a 200,000-hour exposure base equals roughly 100 full-time workers — so establishments with very different headcounts can be compared directly. A TCR below the benchmark signals that controls, training, or automation may be outperforming peers.
Multi-year trend analysis is the single most reliable signal here: a one-year spike could reflect a single severe event, whereas sustained elevation across 2 reporting cycles points to systemic hazard exposure. Readers evaluating Rockland Immunochemicals as an employer, contractor, investment, or regulatory target should examine the yearly DART rate (days away, restricted, or transferred), the fatality count of 0, and any year-over-year deterioration shown in the table below. All figures come directly from employer-submitted OSHA Form 300A summaries — there is no modeling, estimation, or third-party adjustment layered on top of the government data.
Verify This Employer with OSHA
All injury, illness, and fatality figures on this page are sourced from Rockland Immunochemicals's own mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source — name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.
Verify on OSHA Establishment SearchSource: U.S. Department of Labor — OSHA Establishment-Specific Injury and Illness Data. NAICS 325414 — Blood derivatives manufacturing.
DART Rate — Transparent Calculation (2024)
DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.
0 DART incidents × 200,000 ÷ 205,920 hours worked = 0.00 DART
Methodology: 29 CFR 1904 — OSHA Form 300A recordkeeping
Cross-Validating Context — Establishment vs Industry vs State
| Benchmark | TCR | Source |
|---|---|---|
| Rockland Immunochemicals (this establishment) | 0.00 | OSHA ITA Form 300A, 2-year avg |
| Vaccines (i.e., bacterial, virus) manufacturing industry avg | 3.30 | BLS IIF, NAICS 325414 |
| Pennsylvania state avg (all industries) | 18.85 | OSHA ITA, state-level rollup |
Industry benchmarks: Bureau of Labor Statistics — Injuries, Illnesses, and Fatalities (IIF) program
Reportable Incident Timeline
Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by Rockland Immunochemicals to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.
- 2024: 0 reportable incidents · 0 injuries, 0 illnesses, 0 fatalities — OSHA inspection records (case numbers)
- 2023: 0 reportable incidents · 0 injuries, 0 illnesses, 0 fatalities — OSHA inspection records (case numbers)
Source: OSHA Inspection Information System (IMIS) — inspection case-number records
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2023 | 0.0 | 0.0 | 0 | 0 | 0 |
Frequently Asked Questions
What is Rockland Immunochemicals's safety grade?
How is the safety grade calculated?
How many injuries has Rockland Immunochemicals reported?
Where does PlainSafetyScore get its data?
Explore More Safety Data
Read our methodology — how this data is sourced, computed, and verified.